OPC-3 outperforms statin drugs in reducing C-Reactive Proteins

A clinical study of Isotonix OPC-3® showed a 52.1% reduction in C-Reactive proteins in blood plasma compared to a 13-14% reduction when using statin drugs.

C-reactive protein (CRP) is currently the only predictive marker which can forecast the likelihood of a heart attack.  Elevated CRP can also be triggered by infection, cancer, rheumatoid arthritis and other sources of inflammation.

Clinical Study of OPC-3® on CRP’s

Isotonix OPC-3®

4 Comments

  1. OPC Review - An Anti Aging Miracle? said,

    January 22, 2009 at 2:13 am

    […] OPC-3 outperforms statin drugs in reducing C-Reactive Proteins A clinical study of OPC-3 showed a 52.1% reduction in C-Reactive Proteins in blood plasma compared to a 13-14% reduction when using statin drugs. […]

  2. The Power of Isotonic Formulas Compared to Tablets « Engineered for Health said,

    May 28, 2009 at 8:43 pm

    […] D In 2009 a group of researchers in Italy conducted a study to see if an isotonic formula of a known highly effective antioxidant behaved differently on the body compared to the same antioxidant in tablet […]

  3. Sharon A. said,

    February 8, 2015 at 7:29 pm

    Can you use a staton with isotonix?

  4. engineeredforhealth said,

    May 2, 2015 at 10:51 pm

    It’s always best to consult with your health care provider regarding whether or not your medication will be impacted by certain foods and nutritional supplements.

Post a Comment